PRF Technologies (PRFX) Capital Expenditures Growth (1y) (2021 - 2022)

PRF Technologies (PRFX) Capital Expenditures Growth (1y) (2021 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Haleon 89.64 Bn 87.78 Bn - -
2 Teva Pharmaceutical Industries 35.90 Bn 32.16 Bn 1.97 Bn 32.28%
3 Zoetis 32.50 Bn 30.56 Bn 1.62 Bn -38.20%
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn -15.72%
5 United Therapeutics 22.98 Bn 20.83 Bn 648.10 Mn 32.98%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.38 Bn 18.57 Bn 1.16 Bn -6.34%
8 Neurocrine Biosciences 17.78 Bn 16.46 Bn 800.70 Mn -86.92%
9 Elanco Animal Health 12.67 Bn 12.24 Bn 785.00 Mn -21.54%
10 PRF Technologies 699,875.68 -3.44 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 -8,000.00%
Mar 31, 2022 1,946.15%
Mar 31, 2021 77.59%